Press Releases :: Kane Biotech Inc. (KNE)

Skip to main content

Kane Biotech Sells First Set of DispersinB(R) ELISA Kits to MIT, University of Toronto and University of Washington

Feb 1, 2011

DispersinB(R) Wound Spray Passes Final Biocompatibility Sub-Chronic Toxicity Test

Jan 26, 2011

Kane Biotech Announces Grant of Options

Jan 19, 2011

Kane Biotech Retains Pure Advertising & Marketing for Investor Relations

Jan 13, 2011

Kane Biotech Receives $100,000 in Financial Assistance from the Government of Manitoba

Dec 15, 2010

Kane Biotech Issued US Patent for DispersinB(R) Wound Care Technology

Nov 16, 2010

DispersinB(R) Topical Wound Spray Passes Critical Sensitization Test

Nov 8, 2010

Kane Biotech Appoints Board Advisor and Announces Private Placement Offering

Nov 2, 2010

Kane Biotech Selected as One of Canada's Top 10(TM) Life Sciences Companies

Oct 14, 2010

DispersinB(R) Wound Spray Passes First Set of Biocompatibility Tests

Oct 4, 2010